Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
647 hedge funds and large institutions have $11.9B invested in Exact Sciences in 2023 Q4 according to their latest regulatory filings, with 97 funds opening new positions, 215 increasing their positions, 221 reducing their positions, and 67 closing their positions.
45% more first-time investments, than exits
New positions opened: 97 | Existing positions closed: 67
20% more call options, than puts
Call options by funds: $177M | Put options by funds: $147M
7% more capital invested
Capital invested by funds: $11.2B → $11.9B (+$733M)
4% more funds holding
Funds holding: 624 → 647 (+23)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
3% less repeat investments, than reductions
Existing positions increased: 215 | Existing positions reduced: 221
1.35% less ownership
Funds ownership: 90.42% → 89.07% (-1.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$68.4M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$60.4M |
| 3 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$53.8M |
| 4 |
Jennison Associates
New York
|
+$43.2M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$35.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$141M |
| 2 |
JP Morgan Chase
New York
|
-$105M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$51.4M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$49.7M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$48.2M |
EXAS Hedge Fund Activity: Q4 2023 in Review
647 of the 6,870 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q4 2023, worth a combined $11.9B — up 6.6% from $11.2B a quarter earlier.
Buyers outnumbered sellers: 97 funds opened new EXAS positions and 67 closed out — a net gain of 30 holders — while 215 added to existing stakes and 221 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $68.4M. The largest seller was Fidelity Investments, cutting an estimated $141M.
- 647 institutional investors held Exact Sciences (EXAS) as of Q4 2023, up from 624 in Q3 2023.
- Funds reported $11.9B of Exact Sciences stock for Q4 2023, up 6.6% quarter-over-quarter.
- 97 funds opened new Exact Sciences positions in Q4 2023 and 67 closed out, a net change of +30 holders.
- The largest Exact Sciences buyer in Q4 2023 was Citadel Advisors, an estimated $68.4M added.
- The largest Exact Sciences seller in Q4 2023 was Fidelity Investments, an estimated $141M sold.
Based on aggregated 13F filings for Q4 2023.